Metraipolis › archive › dc_050e04350b6d

Design, Synthesis, and Molecular Docking Studies of Novel Pyrazoline-Thiazoles as Cholinesterase Dual-Target Inhibitors for the Treatment of Alzheimer's Disease — Europe PMC PMID:40918343

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40918343
DOI
10.1021/acsomega.5c01055
License (as archived)
solo-consultazione
Archived
2026-11-10T10:49:38.973Z
SHA-256 of the archived text
a006b428c566a8d1e0842be099843a41f70827a3f4869cd88de3751509758a84
Stable URL of this page
https://metraipolis.com/documento/dc_050e04350b6d

How to cite

Design, Synthesis, and Molecular Docking Studies of Novel Pyrazoline-Thiazoles as Cholinesterase Dual-Target Inhibitors for the Treatment of Alzheimer's Disease — Europe PMC PMID:40918343 — Europe PMC (en), https://europepmc.org/article/MED/40918343 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_050e04350b6d (Metraipolis archive dc_050e04350b6d, sha256 a006b428c566a8d1e0842be099843a41f70827a3f4869cd88de3751509758a84)
BibTeX
@misc{dc050e04350b6d,
  title = {Design, Synthesis, and Molecular Docking Studies of Novel Pyrazoline-Thiazoles as Cholinesterase Dual-Target Inhibitors for the Treatment of Alzheimer's Disease — Europe PMC PMID:40918343},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40918343},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_050e04350b6d; sha256 a006b428c566a8d1e0842be099843a41f70827a3f4869cd88de3751509758a84},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40918343. Agents can read the archived copy with the MCP tool read_document.